Eusol Biotech Co.,Ltd. (TPEX:6652)
1.960
0.00 (0.00%)
Apr 9, 2026, 2:59 PM CST
Eusol Biotech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -40.42 | -30.55 | -51.61 | -18.31 | -123.31 |
Depreciation & Amortization | 3.33 | 3.44 | 3.97 | 23.11 | 28.06 |
Other Amortization | 0.11 | 0.06 | 0.06 | 0.08 | 0.16 |
Loss (Gain) From Sale of Assets | -0.78 | -0.21 | -0.04 | -108.66 | - |
Asset Writedown & Restructuring Costs | - | - | - | 51.58 | - |
Loss (Gain) From Sale of Investments | - | - | 12.45 | - | 2 |
Other Operating Activities | 2.97 | -2.76 | -6.86 | 6.16 | -0.06 |
Change in Accounts Receivable | -0.17 | - | -4.59 | -2.36 | 0.01 |
Change in Inventory | -1.87 | - | - | - | - |
Change in Accounts Payable | 2.59 | 0.58 | -1.86 | -8.85 | 3.89 |
Change in Other Net Operating Assets | 1.7 | -2.65 | 5.44 | 4.36 | 0.37 |
Operating Cash Flow | -32.54 | -32.09 | -43.03 | -52.88 | -88.89 |
Capital Expenditures | -2.45 | -0.91 | -0.07 | - | -0.56 |
Sale of Property, Plant & Equipment | 0.78 | 0.43 | 1.11 | 171.64 | - |
Sale (Purchase) of Intangibles | -0.11 | -0.09 | -0.04 | -0.08 | -0.08 |
Investment in Securities | -20.22 | 70.1 | 112.87 | -220.6 | -30 |
Other Investing Activities | -0.25 | -0.04 | - | 0.42 | - |
Investing Cash Flow | -22.25 | 69.49 | 113.87 | -48.63 | -30.64 |
Long-Term Debt Repaid | -2.36 | -2.44 | -2.44 | -3.43 | -4.78 |
Net Debt Issued (Repaid) | -2.36 | -2.44 | -2.44 | -3.43 | -4.78 |
Issuance of Common Stock | - | - | - | - | 300 |
Financing Cash Flow | -2.36 | -2.44 | -2.44 | -3.43 | 295.22 |
Foreign Exchange Rate Adjustments | - | - | 0.64 | 1.51 | -0.44 |
Net Cash Flow | -57.14 | 34.96 | 69.04 | -103.43 | 175.25 |
Free Cash Flow | -34.98 | -32.99 | -43.1 | -52.88 | -89.45 |
Free Cash Flow Margin | -1684.35% | - | - | - | - |
Free Cash Flow Per Share | -0.26 | -0.24 | -0.32 | -0.39 | -0.67 |
Cash Interest Paid | - | - | 0 | - | - |
Cash Income Tax Paid | -2.84 | 0.31 | 9.38 | - | -0.03 |
Levered Free Cash Flow | -23.52 | -28.14 | -30.1 | -25.96 | -43.5 |
Unlevered Free Cash Flow | -23.43 | -28.09 | -30.01 | -25.83 | -43.36 |
Change in Working Capital | 2.25 | -2.06 | -1 | -6.84 | 4.27 |